Moderna
MRNA
NASDAQ
IPO2018
about MRNA
Moderna is a biotechnology company focused on developing vaccines and therapeutic agents using messenger RNA (mRNA) technology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $24.58 | $25.35 | $24.50 | $9.66B | 2.07M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.13 | n/a | 67.65 | -638.73% | -580.99% | 0% |